THE IMPACT OF DECREASING LEVELS OF SERUM HBsAg ON HBsAg SEROCLEARANCE IN CHRONIC HEPATITIS B

被引:0
|
作者
Nagaoka, S. [1 ]
Yatsuhashi, H. [1 ]
Kugiyama, Y. [1 ]
Bekki, S. [1 ]
Sasaki, R. [1 ]
Hashimoto, S. [1 ]
Ohtani, M. [1 ]
Bae, S. K. [1 ]
Saeki, A. [1 ]
Abiru, S. [1 ]
Komori, A. [1 ]
机构
[1] NHO, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan
关键词
D O I
10.1016/S0168-8278(13)60424-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
422
引用
收藏
页码:S173 / S173
页数:1
相关论文
共 50 条
  • [31] Chronic Hepatitis B - Nucleoside Analogues: Therapy changed HBsAg-Serum Levels
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (01): : 4 - 4
  • [32] Re: Do hepatic flares really promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance?
    Nagaoka, Shinya
    Komori, Atsumasa
    Yatsuhashi, Hiroshi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 720 - 720
  • [33] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [34] Prediction of hepatocellular carcinoma in chronic hepatitis B patients following HBsAg seroclearance: Lage score
    Choi, Jonggi
    Kim, Eunju
    Choi, Won-Mook
    Lee, Danbi
    Kim, Kang Mo
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1062 - S1063
  • [35] HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
    Yuen, Man-Fung
    Wong, Danny Ka-Ho
    Fung, James
    Ip, Philip
    But, David
    Hung, Ivan
    Lau, Kevin
    Yuen, John Chi-Hang
    Lai, Ching-Lung
    GASTROENTEROLOGY, 2008, 135 (04) : 1192 - 1199
  • [36] HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection
    Yuen, MF
    Wong, DKH
    Yuan, HJ
    Sum, SM
    Lai, CL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) : 4882 - 4884
  • [37] Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
    Chen, YC
    Sheen, IS
    Chu, CM
    Liaw, YF
    GASTROENTEROLOGY, 2002, 123 (04) : 1084 - 1089
  • [38] Incidence of Hepatocellular Carcinoma after HBsAg seroclearance in Chronic Hepatitis B patients: a need for Surveillance
    Kim, Gi-Ae
    Lee, Han Chu
    Ha, Yeonjung
    Park, Eui Ju
    An, Jihyun
    HEPATOLOGY, 2014, 60 : 972A - 972A
  • [39] Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance
    Arase, Yasuji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Kobayashi, Masahiro
    Akuta, Norio
    Someya, Takashi
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Sato, Junko
    Kobayashi, Mariko
    Ikeda, Kenji
    Kumada, Hiromitsu
    INTERVIROLOGY, 2007, 50 (03) : 161 - 165
  • [40] Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
    Kim, Gi-Ae
    Lee, Han Chu
    Kim, Min-Ju
    Ha, Yeonjung
    Park, Eui Ju
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    JOURNAL OF HEPATOLOGY, 2015, 62 (05) : 1092 - 1099